We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNWD:NASDAQFinward Bancorp Analysis

Data as of 2026-04-04 - not real-time

$35.04

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Finward Bancorp (FNWD) is trading at $35.04, notably above its DCF‑derived fair value of $25.90, suggesting a premium of roughly 35% relative to intrinsic estimates. The stock’s trailing P/E of 18.6 exceeds the regional bank industry average of 16.6, while the P/B ratio of 0.87 indicates a price below book value, offering a partial cushion. Dividend yield stands at 1.37% with a modest payout ratio of 25.5%, and the company generated $9.9 M of operating cash flow, comfortably covering the annual dividend outlay. Low leverage (debt‑to‑equity near zero) and a beta of 0.25 point to limited market‑related volatility, though 30‑day price volatility is elevated at 28% and trading volume is on a downtrend, flagging liquidity concerns.
Technical indicators show the stock below its 20‑day ($36.94) and 50‑day ($36.97) simple moving averages, a bearish MACD histogram, and an RSI of 38, hinting at limited upside momentum in the near term. Support sits at $34.59 and resistance at $38.93, with the market sentiment index at “Extreme Greed” (78.8), suggesting a potential short‑term pullback before any sustained rally. Investors may consider a cautious stance: hold or add on dips for dividend income while monitoring price action around key support levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day and 50‑day SMA
  • Bearish MACD and decreasing volume
  • Proximity to support level at $34.59

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Improving earnings outlook (forward EPS $3.06)
  • Low payout ratio and strong cash flow
  • Low beta indicating defensive profile

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF fair value suggests upside correction risk
  • Stable dividend and solid book value
  • Sector headwinds for regional banks

Key Metrics & Analysis

Financial Health

Revenue Growth-1.90%
Profit Margin12.21%
P/E Ratio18.6
ROE4.96%
ROA0.40%
P/B Ratio0.9
Op. Cash Flow$9.9M
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI38.7
Support$34.59
Resistance$38.93
MA 20$36.94
MA 50$36.97
MA 200$33.57
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Fair Value$25.90
Target Price$39.00
Upside/Downside11.30%
GradeFair
TypeBlend
Dividend Yield1.37%

Risk Assessment

Beta0.25
Volatility28.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.